부산대학교 도서관

Anderson AR; PRISMA Health Comprehensive Sickle Cell Disease Program, Division of Pediatric Hematology-Oncology, University of South Carolina School of Medicine, Greenville, SC.; Strouse JJ; Division of Hematology, Department of Medicine, Duke University School of Medicine, Durham, NC.; Manwani D; Children's Hospital at Montefiore, Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY.; Brandow AM; Department of Pediatrics, Section of Hematology/Oncology/Bone Marrow Transplantation, Medical College of Wisconsin and Children's Research Institute of Children's Wisconsin, Milwaukee, WI.; Vichinsky E; Benioff Children's Hospital Oakland, Department of Pediatrics, UCSF, Oakland, CA.; Campbell A; Department of Pediatrics, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, DC.; Leavey PJ; Simmons Comprehensive Cancer Center, Children's Medical Center, Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX.; Nero A; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX.; Ibrahim IF; Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX.; Field JJ; Department of Medicine, Medical College of Wisconsin, Versiti Blood Research Institute, Milwaukee, WI.; Baer A; Department of Medicine, University of Pennsylvania, Philadelphia, PA.; Soto-Calderon H; Department of Medicine, University of Pennsylvania, Philadelphia, PA.; Vincent L; Department of Medicine, University of Pennsylvania, Philadelphia, PA.; Zhao Y; Department of Microbiology, University of Pennsylvania, Philadelphia, PA.; Santos JJS; Department of Microbiology, University of Pennsylvania, Philadelphia, PA.; Hensley SE; Department of Microbiology, University of Pennsylvania, Philadelphia, PA.; Mortier N; ASH Research Collaborative, Washington, DC.; Lanzkron S; Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Abrams CS; Department of Medicine, University of Pennsylvania, Philadelphia, PA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Cieri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Hookeri N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Stromhaug K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Li L; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Keating J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Díaz-Fernández P; Department of Immunology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain.; Gómez-García de Soria V; Department of Hematology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain.; Stevens J; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Kfuri-Rubens R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Shao Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Kooshesh KA; Harvard Medical School, Boston, MA, USA.; Powell K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ji H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hernandez GM; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Abelin J; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Klaeger S; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Proteomic and Genomic Technologies, Genentech Inc, South San Francisco, CA, USA.; Forman C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Clauser KR; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Sarkizova S; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Braun DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Penter L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Lane WJ; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Kean LS; Harvard Medical School, Boston, MA, USA.; Division Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Carr SA; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Computer Science, Metropolitan College, Boston University, Boston, MA, USA.; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.; Muñoz-Calleja C; Department of Immunology, Instituto de Investigación Sanitaria Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Stewart C; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Getz G; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. catherine_wu@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. catherine_wu@dfci.harvard.edu.

Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE

Zeng YC; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Young OJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Harvard-Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Wintersinger CM; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Anastassacos FM; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; MacDonald JI; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Isinelli G; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Department of Drug and Health Sciences, University of Catania, Catania, Italy.; Dellacherie MO; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; Sobral M; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; Bai H; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Graveline AR; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Vernet A; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Sanchez M; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Mulligan K; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Choi Y; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.; Ferrante TC; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Fell GG; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Mooney DJ; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.; Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.; Kwon IC; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea.; Ryu JH; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. jhryu@kist.re.kr.; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. jhryu@kist.re.kr.; Shih WM; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. william_shih@dfci.harvard.edu.; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA. william_shih@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. william_shih@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101283273 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1748-3395 (Electronic) Linking ISSN: 17483387 NLM ISO Abbreviation: Nat Nanotechnol Subsets: MEDLINE

Nemec R; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Scherrer-Crosbie M; Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Abramson JS; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Redd R; Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USA.; Gilman HK; Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.; Ho T; Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.; Wu J; Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.; Heemelaar J; Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.; Neuberg D; Department of Data Science, Dana Farber Cancer Institute, Boston, MA, USA.; Hochberg EP; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Barnes JA; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kim AI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Friedman RS; Division of Medical Oncology, Newton-Wellesley Hospital, Newton, MA, USA.; LaCasce AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Neilan TG; Division of Cardiology, Massachusetts General Hospital, Boston, MA, USA.; Soumerai JD; Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Takahashi T; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.; Watkins B; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, Georgia.; Bratrude B; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.; Neuberg D; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hebert K; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.; Betz K; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.; Yu A; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.; Choi SW; University of Michigan, Ann Arbor, Michigan.; Davis J; BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.; Duncan C; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.; Giller R; Center for Cancer and Blood Disorders, Children Hospital of Colorado, University of Colorado, Aurora, Colorado.; Grimley M; University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Harris AC; Memorial Sloan Kettering Cancer Center, New York City, New York.; Jacobsohn D; Children's National Health System, Washington, District of Columbia.; Lalefar N; University of California San Francisco, UCSF Benioff Children's Hospital Oakland, Oakland, California.; Farhadfar N; Baptist Medical Center Jacksonville, Jacksonville, Florida.; Pulsipher MA; Spencer Fox Eccles School of Medicine at the University of Utah, Intermountain Primary Children's Hospital, Salt Lake City, Utah.; Shenoy S; Washington University School of Medicine, St Louis, Missouri.; Petrovic A; Seattle Children's Hospital and Fred Hutch Cancer Center, Seattle, Washington.; Schultz KR; BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.; Yanik GA; University of Michigan, Ann Arbor, Michigan.; Blazar BR; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.; Horan JT; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.; Langston A; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Kean LS; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: leslie.kean@childrens.harvard.edu.; Qayed M; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, Georgia.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Iorgulescu JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Ruthen N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Ahn R; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.; Panagioti E; Department of Neurosurgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Gokhale PC; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, United States.; Neagu M; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.; Speranza MC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Eschle BK; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, United States.; Soroko KM; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, United States.; Piranlioglu R; Department of Neurosurgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Datta M; Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.; Department of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, IN, United States.; Krishnan S; Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.; Yates KB; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, United States.; Baker GJ; Laboratory of Systems Pharmacology, Program in Therapeutic Science, Harvard Medical School, Boston, MA, United States.; Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, MA, United States.; Jain RK; Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.; Suvà ML; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, United States.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.; Neuberg D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; White FM; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.; Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.; Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Sharpe AH; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, United States.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Reardon DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Iyengar V; Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medicine, Hematology Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Patell R; Harvard Medical School, Boston, MA.; Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA.; Ren S; Department of Data Science, Dana Farber Cancer Institute, Boston, MA.; Ma S; Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA.; Pinson A; Harvard Medical School, Boston, MA.; Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA.; Barnett A; Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA.; Harvard Medical School, Boston, MA.; Elavalakanar P; Harvard Medical School, Boston, MA.; Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA.; Kazi DS; Harvard Medical School, Boston, MA.; Division of Cardiology, Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, MA.; Neuberg D; Department of Data Science, Dana Farber Cancer Institute, Boston, MA.; Zwicker JI; Department of Medicine, Hematology Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Raghunandan S; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA. sraghu2@emory.edu.; Gorfinkel L; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Bratrude B; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Suessmuth Y; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA.; Hebert K; Dana-Farber Cancer Institute, Boston, MA, USA.; Neuberg D; Dana-Farber Cancer Institute, Boston, MA, USA.; Williams KM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA.; Schoettler ML; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA.; Langston AA; Winship Cancer Institute, Emory University, Atlanta, GA, USA.; Kean LS; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Qayed M; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA.; Horan J; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Watkins BK; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

Stahl A; Division of Hematology, Brigham & Women's Hospital, Boston, Massachusetts, USA.; Barnett K; Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Wilson AK; M Health Fairview Center for Bleeding and Clotting Disorders, Minneapolis, Minnesota, USA.; Ren S; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Park HS; Division of Hematology, Brigham & Women's Hospital, Boston, Massachusetts, USA.; Parnes A; Division of Hematology, Brigham & Women's Hospital, Boston, Massachusetts, USA.

Publisher: Elsevier Country of Publication: United States NLM ID: 101703775 Publication Model: eCollection Cited Medium: Internet ISSN: 2475-0379 (Electronic) Linking ISSN: 24750379 NLM ISO Abbreviation: Res Pract Thromb Haemost Subsets: PubMed not MEDLINE

Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Lemvigh CK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.; Deng S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Dangle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ruthen N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Knisbacher BA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Broséus J; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France; Université de Lorraine, CHRU-Nancy, Service d'hématologie Biologique, Pôle Laboratoires, 54000 Nancy, France.; Hergalant S; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France.; Guièze R; CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France; EA 7453 (CHELTER), Université Clermont Auvergne, 63001 Clermont-Ferrand, France.; Li S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Zhang W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Johnson C; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Long JM; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA; Division of Gastroenterology, Hepatology, and Nutrition, Boston Children's Hospital, Boston, MA 02115, USA.; Yin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Werner L; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Anandappa A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Purroy N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Gohil S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA.; Bachireddy P; Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Shukla SA; Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Huang T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Khoury JD; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.; Thakral B; Department of Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.; Dickinson M; Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Tam C; Alfred Health, Melbourne, VIC, Australia; Monash University, Melbourne, VIC, Australia.; Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Getz G; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Neuberg D; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Feugier P; Inserm UMRS1256 Nutrition-Génétique et Exposition Aux Risques Environnementaux (N-GERE), Université de Lorraine, 54000 Nancy, France; Université de Lorraine, CHRU Nancy, service d'hématologie clinique, Nancy, France.; Kharchenko P; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02215, USA.; Wierda W; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.; Olsen LR; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.; Jain N; Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: Catherine_wu@dfci.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE